SCHEMBL1362788

SCHEMBL1362788

Cc1ccc(CCN)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19438869 0.91 PRMT6 (0.47)
SCHEMBL8105246 0.89 PRMT6 (0.45)
SCHEMBL23665620 0.85 PRMT6 (0.58)
Dimethylamine SCHEMBL11463227 0.84 PRMT6 (0.50)
SCHEMBL6565066 0.82 TAAR1 (0.50)
SCHEMBL128771 0.80
SCHEMBL8119863 0.80 PRMT6 (0.41)
SCHEMBL9479561 0.79 PRMT6 (0.48)
SCHEMBL147077 0.78
Hydrochloric Acid SCHEMBL13731096 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119198973-B Method for detecting liquid phase content of BHT and EMQ in solid antioxidant 杭州大耳鱼生物科技合伙企业(有限合伙) 2025-03-21 CN claimed
CN-119198973-A Method for detecting liquid phase content of BHT and EMQ in solid antioxidant 杭州大耳鱼生物科技合伙企业(有限合伙) 2024-12-27 CN claimed
CN-119198973-B Method for detecting liquid phase content of BHT and EMQ in solid antioxidant 杭州大耳鱼生物科技合伙企业(有限合伙) 2025-03-21 CN disclosed
CN-119198973-A Method for detecting liquid phase content of BHT and EMQ in solid antioxidant 杭州大耳鱼生物科技合伙企业(有限合伙) 2024-12-27 CN disclosed
EP-2848617-B1 DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2022-01-12 EP disclosed
CN-108203451-B Organometallic complex and organic light emitting diode including the same 财团法人工业技术研究院 2021-07-20 CN disclosed
US-10164199-B2 Organic metal compound and organic light-emitting device employing the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2018-12-25 US disclosed
CN-108203451-A Organometallic complex and organic light emitting diode including the same 财团法人工业技术研究院 2018-06-26 CN disclosed
US-20180175309-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2018-06-21 US disclosed
US-20180175309-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2018-06-21 US disclosed
US-20180175309-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2018-06-21 US disclosed
US-7265246-B2 Indane derivates as muscarinic receptor agonists ELI LILLY AND COMPANY (US) 2007-09-04 US disclosed
US-20070093482-A1 THIENO-IMINO ACID DERIVATIVES FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-04-26 US disclosed
US-20070060587-A1 Indane derivates as muscarinic receptor agonists ELI LILLY AND COMPANY (US) 2007-03-15 US disclosed
EP-1723148-A2 THIENO-IMINO ACID DERIVATIVES FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS Sanofi-Aventis Deutschland GmbH (DE) 2006-11-22 EP disclosed
EP-1720836-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2006-11-15 EP disclosed
EP-1644320-A1 INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2006-04-12 EP disclosed
WO-2005082859-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2005-09-09 WO disclosed
WO-2005073236-A2 THIENO-IMINO ACID DERIVATIVES FOR USE AS MATRIX METALLOPROTEINASE INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-08-11 WO disclosed
WO-2005009941-A1 INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2005-02-03 WO disclosed